Published in Nature on March 01, 2009
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
Inflammatory caspases are innate immune receptors for intracellular LPS. Nature (2014) 4.88
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48
Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol (2010) 4.07
The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol (2013) 3.59
Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov (2010) 3.35
DAMPening inflammation by modulating TLR signalling. Mediators Inflamm (2010) 3.29
Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol (2010) 3.15
Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab (2012) 2.96
Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res (2011) 2.89
Hyaluronan as an immune regulator in human diseases. Physiol Rev (2011) 2.74
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med (2012) 2.60
Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. Cell (2014) 2.59
Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. Proc Natl Acad Sci U S A (2013) 2.45
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant. PLoS One (2011) 2.39
Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev (2009) 2.30
Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun (2009) 2.19
A mouse macrophage lipidome. J Biol Chem (2010) 2.14
Structural basis of steroid hormone perception by the receptor kinase BRI1. Nature (2011) 2.12
Structural basis of TLR5-flagellin recognition and signaling. Science (2012) 2.10
Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol (2011) 2.04
Structural insight into brassinosteroid perception by BRI1. Nature (2011) 2.04
The structural biology of Toll-like receptors. Structure (2011) 2.04
Molecular basis of NF-κB signaling. Annu Rev Biophys (2013) 2.03
Alcoholic liver disease and the gut-liver axis. World J Gastroenterol (2010) 2.02
Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol (2012) 2.00
Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat Rev Microbiol (2013) 1.88
Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol (2009) 1.87
Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol (2012) 1.86
Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in gram-positive and gram-negative bacteria. Proc Natl Acad Sci U S A (2012) 1.83
Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc Natl Acad Sci U S A (2012) 1.80
Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res (2012) 1.79
The molecular basis of the host response to lipopolysaccharide. Nat Rev Microbiol (2010) 1.70
Toll-like receptor 4 in CNS pathologies. J Neurochem (2010) 1.68
Enterocyte microvillus-derived vesicles detoxify bacterial products and regulate epithelial-microbial interactions. Curr Biol (2012) 1.67
Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol (2015) 1.66
CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med (2010) 1.64
Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc Natl Acad Sci U S A (2012) 1.63
Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J Neurosci (2012) 1.55
Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol (2014) 1.48
Brain angiogenesis inhibitor 1 (BAI1) is a pattern recognition receptor that mediates macrophage binding and engulfment of Gram-negative bacteria. Proc Natl Acad Sci U S A (2011) 1.47
Modulating the innate immune response by combinatorial engineering of endotoxin. Proc Natl Acad Sci U S A (2013) 1.45
Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med (2013) 1.41
Genome-wide expression profiling implicates a MAST3-regulated gene set in colonic mucosal inflammation of ulcerative colitis patients. Inflamm Bowel Dis (2011) 1.41
Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLoS Pathog (2011) 1.40
Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res (2010) 1.40
Toll-like receptor signaling in vertebrates: testing the integration of protein, complex, and pathway data in the protein ontology framework. PLoS One (2015) 1.40
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies. Expert Opin Drug Metab Toxicol (2011) 1.36
Structure and functional analysis of LptC, a conserved membrane protein involved in the lipopolysaccharide export pathway in Escherichia coli. J Biol Chem (2010) 1.35
MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation. J Biol Chem (2009) 1.35
Adaptation and constraint at Toll-like receptors in primates. Mol Biol Evol (2010) 1.34
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta. Neuroscience (2010) 1.33
Sensors of the innate immune system: their mode of action. Nat Rev Rheumatol (2009) 1.31
The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. J Immunol (2012) 1.31
Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med (2009) 1.29
Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol (2013) 1.27
TLR4 and Insulin Resistance. Gastroenterol Res Pract (2010) 1.27
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J Exp Med (2015) 1.25
Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development. Infect Immun (2009) 1.25
Structural basis for lipopolysaccharide insertion in the bacterial outer membrane. Nature (2014) 1.24
NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity (2014) 1.24
Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway and proinflammatory response in human pericytes. J Biol Chem (2013) 1.23
Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience (2010) 1.22
The lipid A phosphate position determines differential host Toll-like receptor 4 responses to phylogenetically related symbiotic and pathogenic bacteria. Infect Immun (2010) 1.22
Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily. Sci Signal (2012) 1.20
New insights for development of a safe and protective RSV vaccine. Hum Vaccin (2010) 1.18
Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev (2015) 1.18
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci (2014) 1.18
Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis. Periodontol 2000 (2010) 1.17
The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. PLoS Pathog (2012) 1.17
Signatures of positive selection in Toll-like receptor (TLR) genes in mammals. BMC Evol Biol (2011) 1.17
Host defense at the ocular surface. Int Rev Immunol (2013) 1.16
Signaling organelles of the innate immune system. Cell (2012) 1.15
Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. J Immunol (2011) 1.15
Heme on innate immunity and inflammation. Front Pharmacol (2014) 1.15
Characterization of sparstolonin B, a Chinese herb-derived compound, as a selective Toll-like receptor antagonist with potent anti-inflammatory properties. J Biol Chem (2011) 1.14
Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol (2011) 1.14
Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol (2013) 1.14
Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist. Sci Signal (2012) 1.13
Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica. PLoS Pathog (2012) 1.13
Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? Br J Pharmacol (2010) 1.12
The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants. Shock (2013) 1.12
Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application. Mediators Inflamm (2010) 1.11
Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I. J Biol Chem (2012) 1.11
Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wild-type TLR4. J Immunol (2010) 1.10
The toll-like receptor 3:dsRNA signaling complex. Biochim Biophys Acta (2009) 1.10
Innate immune responses to bacterial ligands in the peripheral human lung--role of alveolar epithelial TLR expression and signalling. PLoS One (2011) 1.09
An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1. Nat Struct Mol Biol (2011) 1.09
Crystal structure of soluble MD-1 and its interaction with lipid IVa. Proc Natl Acad Sci U S A (2010) 1.09
Toll-like receptor 4 and MYD88-dependent signaling mechanisms of the innate immune system are essential for the response to lipopolysaccharide by epithelial and stromal cells of the bovine endometrium. Biol Reprod (2012) 1.08
Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience (2010) 1.07
Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance. J Biol Chem (2010) 1.07
Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. Cold Spring Harb Perspect Biol (2014) 1.07
Similar Structures but Different Roles - An Updated Perspective on TLR Structures. Front Physiol (2011) 1.06
Molecular modeling-based evaluation of hTLR10 and identification of potential ligands in Toll-like receptor signaling. PLoS One (2010) 1.05
MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid IVA. J Biol Chem (2010) 1.05
A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol (2014) 1.05
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins (2003) 32.38
Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr (2005) 29.38
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 23.92
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med (1999) 9.23
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell (2007) 6.84
Biochemistry of endotoxins. Annu Rev Biochem (1990) 6.75
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell (2007) 6.55
Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J (1994) 5.70
Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol (2003) 5.46
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science (2007) 4.90
Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science (2008) 4.41
Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science (2007) 4.01
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem (1985) 3.76
Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science (2005) 3.72
Structures of the toll-like receptor family and its ligand complexes. Immunity (2008) 3.36
The leucine-rich repeat structure. Cell Mol Life Sci (2008) 3.18
The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci U S A (2005) 2.71
Structure and function of lipopolysaccharides. Microbes Infect (2002) 2.49
Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa. J Immunol (2008) 1.90
Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics (2007) 1.80
Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J Biol Chem (2003) 1.78
Molecular basis of reduced potency of underacylated endotoxins. J Immunol (2005) 1.77
The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology (1993) 1.69
Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J Immunol (2006) 1.69
Roles for accessory molecules in microbial recognition by Toll-like receptors. J Endotoxin Res (2006) 1.59
Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness. J Immunol (2003) 1.54
Novel roles in human MD-2 of phenylalanines 121 and 126 and tyrosine 131 in activation of Toll-like receptor 4 by endotoxin. J Biol Chem (2007) 1.36
TLR4 antagonists for endotoxemia and beyond. Curr Opin Investig Drugs (2005) 1.34
Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures. Infect Immun (1992) 1.20
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell (2007) 6.84
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell (2007) 6.55
Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity (2009) 3.91
CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest (2010) 3.60
Structures of the toll-like receptor family and its ligand complexes. Immunity (2008) 3.36
Structural diversity of the hagfish variable lymphocyte receptors. J Biol Chem (2006) 1.89
Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Res (2006) 1.78
Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J Biol Chem (2005) 1.70
Structural biology of the Toll-like receptor family. Annu Rev Biochem (2011) 1.66
Interactions of PAN's C-termini with archaeal 20S proteasome and implications for the eukaryotic proteasome-ATPase interactions. EMBO J (2009) 1.60
Binding surface mapping of intra- and interdomain interactions among hHR23B, ubiquitin, and polyubiquitin binding site 2 of S5a. J Biol Chem (2003) 1.52
Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. Nature (2003) 1.51
Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci U S A (2007) 1.50
Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med (2013) 1.41
Sensing of microbial molecular patterns by Toll-like receptors. Immunol Rev (2012) 1.39
Structure of PP4397 reveals the molecular basis for different c-di-GMP binding modes by Pilz domain proteins. J Mol Biol (2010) 1.34
Kinetics of binding of LPS to recombinant CD14, TLR4, and MD-2 proteins. Mol Cells (2007) 1.26
CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells. Immunity (2002) 1.18
Crystal structure of phosphodiesterase 4D and inhibitor complex(1). FEBS Lett (2002) 1.14
Rapid preparation of RNA samples for NMR spectroscopy and X-ray crystallography. Nucleic Acids Res (2004) 1.09
Activation of Ras up-regulates pro-apoptotic BNIP3 in nitric oxide-induced cell death. J Biol Chem (2006) 1.06
The protein shuffle. Sequential interactions among components of the human nucleotide excision repair pathway. FEBS J (2006) 1.05
Structures of TLR-ligand complexes. Curr Opin Immunol (2008) 1.02
Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril. FEBS Lett (2003) 0.99
Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation. Nat Struct Biol (2003) 0.99
A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis. Biochim Biophys Acta (2009) 0.99
Crystal structure of the human N-Myc downstream-regulated gene 2 protein provides insight into its role as a tumor suppressor. J Biol Chem (2011) 0.99
A method for integrative structure determination of protein-protein complexes. Bioinformatics (2012) 0.97
Reconfiguration of the proteasome during chaperone-mediated assembly. Nature (2013) 0.96
Application of hybrid LRR technique to protein crystallization. BMB Rep (2008) 0.95
NMR spectroscopic elucidation of the B-Z transition of a DNA double helix induced by the Z alpha domain of human ADAR1. J Am Chem Soc (2009) 0.95
Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation. J Biol Chem (2011) 0.94
Nitric oxide induces BNIP3 expression that causes cell death in macrophages. Biochem Biophys Res Commun (2004) 0.92
Residual structure within the disordered C-terminal segment of p21(Waf1/Cip1/Sdi1) and its implications for molecular recognition. Protein Sci (2009) 0.92
The human Cdc34 carboxyl terminus contains a non-covalent ubiquitin binding activity that contributes to SCF-dependent ubiquitination. J Biol Chem (2010) 0.91
Silencing of BNIP3 results from promoter methylation by DNA methyltransferase 1 induced by the mitogen-activated protein kinase pathway. Mol Cells (2011) 0.90
Structural and dynamic basis of a supercoiling-responsive DNA element. Nucleic Acids Res (2006) 0.90
Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2. Life Sci (2009) 0.90
Subcellular in vivo 1H MR spectroscopy of Xenopus laevis oocytes. Biophys J (2005) 0.89
Cnu, a novel oriC-binding protein of Escherichia coli. J Bacteriol (2005) 0.89
NMR application probes a novel and ubiquitous family of enzymes that alter monosaccharide configuration. J Biol Chem (2004) 0.89
Intrinsically unstructured N-terminal domain of bZIP transcription factor HY5. Proteins (2006) 0.89
Cytosolic NADP(+)-dependent isocitrate dehydrogenase protects macrophages from LPS-induced nitric oxide and reactive oxygen species. Biochem Biophys Res Commun (2004) 0.89
The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity. Immunity (2013) 0.88
Structure and function of the regulatory HRDC domain from human Bloom syndrome protein. Nucleic Acids Res (2010) 0.88
Toll-like receptor 4 decoy, TOY, attenuates gram-negative bacterial sepsis. PLoS One (2009) 0.88
Solution structure of the DNA-binding domain of RPA from Saccharomyces cerevisiae and its interaction with single-stranded DNA and SV40 T antigen. Nucleic Acids Res (2005) 0.87
A single-nucleotide natural variation (U4 to C4) in an influenza A virus promoter exhibits a large structural change: implications for differential viral RNA synthesis by RNA-dependent RNA polymerase. Nucleic Acids Res (2003) 0.87
Simvastatin induces caspase-independent apoptosis in LPS-activated RAW264.7 macrophage cells. Biochem Biophys Res Commun (2005) 0.86
Direct characterization of E2-dependent target specificity and processivity using an artificial p27-linker-E2 ubiquitination system. BMB Rep (2008) 0.86
Structural characterization reveals that a PilZ domain protein undergoes substantial conformational change upon binding to cyclic dimeric guanosine monophosphate. Protein Sci (2010) 0.86
Solution structure of the influenza A virus cRNA promoter: implications for differential recognition of viral promoter structures by RNA-dependent RNA polymerase. Nucleic Acids Res (2003) 0.85
NMR study on the interaction between RPA and DNA decamer containing cis-syn cyclobutane pyrimidine dimer in the presence of XPA: implication for damage verification and strand-specific dual incision in nucleotide excision repair. Nucleic Acids Res (2003) 0.85
Higd-1a interacts with Opa1 and is required for the morphological and functional integrity of mitochondria. Proc Natl Acad Sci U S A (2013) 0.85
Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex. J Biol Chem (2005) 0.85
NMR analysis of enzyme-catalyzed and free-equilibrium mutarotation kinetics of monosaccharides. J Am Chem Soc (2004) 0.84
Regulation of CD40 reconstitution into a liposome using different ratios of solubilized LDAO to lipids. Colloids Surf B Biointerfaces (2007) 0.84
Structural and dynamics study of DNA dodecamer duplexes that contain un-, hemi-, or fully methylated GATC sites. J Am Chem Soc (2008) 0.84
Structure of the N-terminal extension of human aspartyl-tRNA synthetase: implications for its biological function. Int J Biochem Cell Biol (2003) 0.84
Structural basis for the conformational integrity of the Arabidopsis thaliana HY5 leucine zipper homodimer. J Biol Chem (2007) 0.84
NMR study on the B-Z junction formation of DNA duplexes induced by Z-DNA binding domain of human ADAR1. J Am Chem Soc (2012) 0.83
Structure of the nucleoid-associated protein Cnu reveals common binding sites for H-NS in Cnu and Hha. Biochemistry (2008) 0.83
The survival effect of mitochondrial Higd-1a is associated with suppression of cytochrome C release and prevention of caspase activation. Biochim Biophys Acta (2011) 0.83
A critical role for the histidine residues in the catalytic function of acyl-CoA:cholesterol acyltransferase catalysis: evidence for catalytic difference between ACAT1 and ACAT2. FEBS Lett (2006) 0.83
Structure and dynamics of hemimethylated GATC sites: implications for DNA-SeqA recognition. J Biol Chem (2003) 0.83
Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells. Ann Surg Oncol (2011) 0.82
NMR structure of the DNA decamer duplex containing double T*G mismatches of cis-syn cyclobutane pyrimidine dimer: implications for DNA damage recognition by the XPC-hHR23B complex. Nucleic Acids Res (2004) 0.82
TNF ligands: is TALL-1 a trimer or a virus-like cluster? Nature (2004) 0.82
Leucine-rich repeat-containing G-protein coupled receptor 5/GPR49 activates G12/13-Rho GTPase pathway. Mol Cells (2013) 0.82
A novel small-molecule binds to the influenza A virus RNA promoter and inhibits viral replication. Chem Commun (Camb) (2013) 0.82
Structural basis for ovarian tumor domain-containing protein 1 (OTU1) binding to p97/valosin-containing protein (VCP). J Biol Chem (2014) 0.82
Thermodynamics and kinetics for base pair opening in the DNA decamer duplexes containing cyclobutane pyrimidine dimer. FEBS Lett (2009) 0.82
Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer. Cancer Chemother Pharmacol (2014) 0.81
Structural insights into the monosaccharide specificity of Escherichia coli rhamnose mutarotase. J Mol Biol (2005) 0.81
Inhibitory effect of a phosphatidyl ethanolamine derivative on LPS-induced sepsis. Mol Cells (2009) 0.81
Structural insights into the regulation of sialic acid catabolism by the Vibrio vulnificus transcriptional repressor NanR. Proc Natl Acad Sci U S A (2013) 0.81
Srs2 possesses a non-canonical PIP box in front of its SBM for precise recognition of SUMOylated PCNA. J Mol Cell Biol (2012) 0.81
Ultrasound-guided infraclavicular axillary vein puncture is effective to avoid pinch-off syndrome: a long-term follow-up study. Surg Today (2012) 0.81